B / Growth hormone axis
CJC-1295 10 mg
CJC-1295 is supplied as 10 mg of lyophilised powder in a sealed 2R vial. Every vial is filled, tested and released by lot in our own facility.
- 10 mgNet quantity
- 2RPresentation
- 01Compounds
- 2 to 8 °CStorage
The turn
Six angles from the turntable. The back panel carries the lot field, the barcode and the code that resolves to the certificate.
Turntable render. The lot and the codes printed on the back panel are format specimens, not a lot in supply.
Turn the vial
The vial as it is made: glass, cake, stopper, aluminium crimp, copper cap and the printed label.
Technical sheet
What the product is, stated as identifiers. Lot values are on the certificate and nowhere else.
| Product | CJC-1295 10 mg |
|---|---|
| Net quantity | 10 mg |
| Product code | 06 The two digits that open the barcode and the QR path printed on the label. |
| Presentation | 2R tubular glass vial, 13 mm crimp |
| Glass format | 2R · 3 ml · 13 mm flip-off |
| Kind | Lyophilised powder, single compound |
| Compound | CJC-1295 |
| Compound kind | Peptide |
| CAS number | 863288-34-0 |
| Molecular formula | C152H252N44O42 |
| PubChem CID | 91971820 Open PubChem CID 91971820 |
| Sequence | H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 |
| Residues | 29 residues |
| Formula variance | The catalogue formula and the PubChem record differ. The registry note is printed as written. The CAS listed is the DAC form and the formula the no-DAC form. This record is provisional and one of the two will be corrected. |
| Registry note, verbatim | The catalogue pairs the DAC CAS (863288-34-0) with the NO-DAC formula (Mod GRF 1-29). PubChem's record for that CAS is the DAC variant. Registry entries are kept in English. PubChem: C165H269N47O46. |
| Storage | 2 to 8 °C, protected from light |
| Use | Research use only. Not for human consumption. |
| Lot format | LYT-0000-X Format shown. Not a lot in supply. |
| Certificate | Look up a lot The certificate for a lot opens from the lookup once it is published. |
How this lot was made
Five steps between the sequence and this sealed vial, each with its control and its record.
- 01
Synthesis
Sequences are assembled by solid-phase peptide synthesis, residue by residue.
Step 01 on the process page - 02
Purification
Crude peptide is purified by preparative HPLC. Fractions are pooled against the purity specification.
Step 02 on the process page - 03
- 04
Fill and finish
Vials are filled by mass, stoppered and crimp-sealed with an aluminium cap.
Step 04 on the process page - 05
Release testing
Each lot is tested for HPLC purity and pH, then released with its certificate.
Step 05 on the process page
Schematic. No lot values are shown.
Released by lot, with its certificate
A lot of this product is not supplied until it is tested. Release is a decision against a written specification, taken once per lot.
- The lot is tested for purity by HPLC and for pH.
- Results are compared against the specification, not against the previous lot.
- A lot that does not meet the specification is not released.
Each lot is released against a written purity specification. The result for a lot is on its certificate.
Purity is confirmed by an independent third-party laboratory alongside our own release testing.
Look up a lot of CJC-1295
Enter the lot number printed on the CJC-1295 label.Accepted format LYT-0000-X
Further lot documentation is available to distributors and research organisations on request.
Also in group B
Growth hormone axis. The other products indexed beside this one.
Enquiries
Documentation and distribution enquiries reach the laboratory directly. This site publishes no prices and takes no orders.